Variation of inflammatory parameters after sibutramine treatment compared to placebo in type 2 diabetic patients.
Derosa, G. MD PhD 1; Maffioli, P. MD 1; Ferrari, I. MD 1; Palumbo, I. MD 1; Randazzo, S. MD 1; D'Angelo, A. BD PhD 1; Cicero, A. F. G. MD PhD 2
[Article] Journal of Clinical Pharmacy & Therapeutics. 36(5):592-601, October 2011.

(Format: HTML, PDF)